Oral anticoagulants in patients with atrial fibrillation and end-stage renal disease: Walking the tightrope between thromboembolic and bleeding risk

被引：0
|
作者：
Vitolo, Marco [1 ,2 ]
Gerra, Luigi [1 ]
Boriani, Giuseppe [1 ]
机构：
[1] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Cardiol Div, Policlin Modena, Modena, Italy
[2] Univ Modena & Reggio Emilia, Clin & Expt Med PhD Program, Modena, Italy
来源：
EUROPEAN JOURNAL OF INTERNAL MEDICINE | 2024年 / 119卷
关键词：
Atrial fibrillation; End -stage renal disease; Oral anticoagulants; Dialysis; NOACs; Chronic kidney disease; HEMODIALYSIS; APIXABAN; STROKE;
D O I：
10.1016/j.ejim.2023.10.030
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：39 / 41
页数：3
相关论文
共 50 条
  • [1] Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease
    Zaman, Junaid A. B.
    Bhandari, Anil K.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2019, 24 (06) : 499 - 508
  • [2] Anticoagulants in Patients with Atrial Fibrillation and End-Stage Renal Disease
    Brimble, K. Scott
    Ingram, Alistair J.
    Eikelboom, John W.
    Hart, Robert G.
    [J]. POSTGRADUATE MEDICINE, 2012, 124 (06) : 17 - 25
  • [3] Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease
    Nishimura, Marin
    Hsu, Jonathan C.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (01): : 131 - 140
  • [4] Direct oral anticoagulants for oral anticoagulants-naïve Asian patients with atrial fibrillation and end-stage renal disease undergoing dialysis
    Roh, Jae-Hyung
    Kim, Yong-Giun
    Kim, Doyeon
    Park, Sangwoo
    Park, Kyung Sun
    Kim, Minsu
    Hwang, Ki Won
    Hwang, Wonmook
    Park, Gyung-Min
    Lee, Jae-Hwan
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [5] Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease
    Pokorney, Sean D.
    Black-Maier, Eric
    Hellkamp, Anne S.
    Friedman, Daniel J.
    Vemulapalli, Sreekanth
    Granger, Christopher B.
    Thomas, Laine
    Peterson, Eric D.
    Piccini, Jonathan P., Sr.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1299 - 1308
  • [6] Atrial fibrillation in end-stage renal disease
    Korantzopoulos, Panagiotis
    Kokkoris, Stelios
    Liu, Tong
    Protopsaltis, Ioannis
    Li, Guangping
    Goudevenos, John A.
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2007, 30 (11): : 1391 - 1397
  • [7] Efficacy of Oral Anticoagulants (Warfarin) in End-Stage Renal Disease Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis
    Al Al-Shaikh, Al-Anoud Farraj
    AlRashod, Abdullah Dakhel
    Al-Amri, Dhafer Ali
    Al-Ghamdi, Omar Mohammed
    Al-Shahrani, Othman Mohammed
    Al-Asmari, Fawzia Saeed
    Al-Johani, Reem Rizqallah
    Aldhahri, Shoaa Khalid
    Hakami, Abdullah Mohammed
    Alalyani, Wafaa Mohammed
    [J]. ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH, 2020, 10 (04) : 954 - +
  • [8] End-stage renal disease with atrial fibrillation: uncharted territory in the modern world of anticoagulants
    Browne, Sandra D.
    McMaster, Justin
    Rizvi, Syed A.
    Ahmed, Sultan
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (12) : 1639 - 1642
  • [9] Direct Oral Anticoagulants in End-Stage Renal Disease
    Klil-Drori, Adi J.
    Tagalakis, Vicky
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2018, 44 (04): : 353 - 363
  • [10] Use of novel oral anticoagulants in patients with end-stage renal disease
    Winkelmayer, Wolfgang C.
    Herzog, Charles A.
    Montez-Rath, Maria E.
    Chang, Tara I.
    Chertow, Glenn M.
    [J]. HEMODIALYSIS INTERNATIONAL, 2015, 19 (01) : 150 - 153
12345